The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers - Trial NCT06243809
Access comprehensive clinical trial information for NCT06243809 through Pure Global AI's free database. This Phase 1 trial is sponsored by International Bio service and is currently Not yet recruiting. The study focuses on Healthy Volunteer. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
International Bio service
Timeline & Enrollment
Phase 1
Apr 24, 2024
Jul 02, 2024
Primary Outcome
Plasma Area Under the Curve (AUC(0 to 72hr)) for Linagliptin,Peak Plasma Concentration (Cmax) of Linagliptin
Summary
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic
 Linagliptin 5 mg Film-coated Tablet (LINIPTIN) and Reference Product (Trajentaยฎ) in Healthy
 Thai Volunteers under Fasting Conditions
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06243809
Non-Device Trial

